Tandem Diabetes Care (FRA:TD5A) Tax Provision : €-2.2 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care Tax Provision?

Tandem Diabetes Care's tax provision for the three months ended in Dec. 2023 was €1.2 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.2 Mil.

Tandem Diabetes Care Tax Provision Historical Data

The historical data trend for Tandem Diabetes Care's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Tax Provision Chart

Tandem Diabetes Care Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-0.13

1.56

-0.30

-1.64

-2.16

Tandem Diabetes Care Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Tax Provision	Get a 7-Day Free Trial															0.25	-0.27	-1.06	-2.09	1.20

Tandem Diabetes Care Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.2 Mil.

Tandem Diabetes Care (FRA:TD5A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

TNDM:USA

Address

11075 Roselle Street, San Diego, CA, USA, 92121

Website

https://www.tandemdiabetes.com

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care (FRA:TD5A) Headlines

No Headlines